CD19 (Inebilizumab Biosimilar) anticorps (Biotin)

N° du produit ABIN7607793

Cet anticorps anti-CD19 (Inebilizumab Biosimilar) est un anticorps Humanized Monoclonal détectant CD19 (Inebilizumab Biosimilar) dans ELISA et FACS. Adapté pour Humain.

Aperçu rapide pour CD19 (Inebilizumab Biosimilar) anticorps (Biotin) (ABIN7607793)

Antigène: CD19 (Inebilizumab Biosimilar)

Reactivité: Humain

Hôte: Humanized

Clonalité: Monoclonal

Conjugué: Cet anticorp CD19 (Inebilizumab Biosimilar) est conjugé à/à la Biotin

Application: ELISA, Flow Cytometry (FACS)

Détail du produit anti-CD19 (Inebilizumab Biosimilar) anticorps (Biotin)

Fonction: Biotinylated Anti-CD19 (inebilizumab biosimilar)mAb

Isotype: IgG1

Information d'application

Indications d'application: ELISA 1:5000-10000, Flow Cyt 1:100

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Détails sur CD19 (Inebilizumab Biosimilar)

Antigène: CD19 (Inebilizumab Biosimilar)

Autre désignation: inebilizumab Biosimilar

Classe de substances: Biosimilar

Sujet: Synonyms Target:CD19,4,VID3,GC12802
Synonyms Antibody:MEDI-551,Medi-551